CION Cancer Clinics
Continuing antiviral treatment after liver cancer treatment | CION Cancer Clinics
If you have hepatitis B, your antiviral tablets almost always continue after liver cancer treatment. Surgery, ablation or TACE treats the tumour, not the virus, and stopping the tablets can cause a dangerous flare in a liver that is already weakened. This page explains why the antiviral continues, how to keep it going through cancer care, and what is different with hepatitis C. At CION Cancer Clinics, our team supports patients and families through symptoms, follow-up and life during and after treatment.
On this page
- Should I keep taking my hepatitis B tablets after liver cancer treatment?
- Why can't the antiviral stop once the tumour is treated?
- How do I keep the antiviral going through cancer treatment?
- What do families often believe about these tablets?
- What if I have hepatitis C, or no hepatitis at all?
- What this page cannot tell you
- Common questions about antivirals after liver cancer
The short answer
Should I keep taking my hepatitis B tablets after liver cancer treatment?
Yes, in almost every case. Hepatitis B antivirals keep the virus controlled. Treating the cancer does nothing to the virus, so the tablets need to continue after surgery, ablation, TACE or any other cancer treatment, unless your liver doctor tells you otherwise.
Controlled, not removed
Hepatitis B is controlled by tablets rather than removed from the body. Tablets such as tenofovir and entecavir stop the virus multiplying, but it stays hidden inside liver cells. If the tablets stop, it can wake up. In a liver that has just been through cancer treatment, a sudden flare of the virus can be serious. Our page on why stopping hepatitis B medicine is risky explains this in more detail.
Why it matters more after cancer
Keeping the virus quiet protects the liver you still have. It lowers ongoing inflammation, which helps the liver cope with treatment and lowers the chance of a new tumour growing elsewhere in the liver. A steady liver also leaves more treatment choices open later, if they are ever needed.
The decision to start, change or stop an antiviral belongs to your hepatologist or physician, with your oncologist kept informed.Reasons it continues
Why can't the antiviral stop once the tumour is treated?
The tumour and the virus are two different problems. Cancer treatment is aimed at one. The tablets are aimed at the other.
The virus outlives the tumour
Removing or destroying a tumour does not remove hepatitis B from the rest of the liver. The virus remains in the cells that are left, so the reason for treating it remains too.
Cancer treatment can wake the virus
Chemotherapy, steroids and some other cancer medicines weaken the body's hold on the virus. This is called reactivation. Staying on the antiviral is the main protection against it.
Medicines where this is checked
- Chemotherapy
- Steroids given for side effects
- Immunotherapy, which needs care with hepatitis B
A flare can tip a weak liver over
A liver with cirrhosis and a recent operation or TACE has less in reserve. A burst of viral activity on top of that can bring on jaundice, fluid in the abdomen or confusion.
Lower activity, lower new-tumour risk
Antivirals lower the risk of liver cancer in people with hepatitis B. They do not remove it. That benefit is still worth having after a first tumour has been treated.
Not sure whether this applies to you?
Ask an oncologistDay to day
How do I keep the antiviral going through cancer treatment?
Tell every team you are on it
Your surgeon, oncologist, anaesthetist and any hospital ward need to know. Write the medicine name on a card in your wallet and keep a photo of the strip on your phone.
Do not stop for a procedure unless told
On the day of surgery or TACE, ask the team how to take it. Most people continue. If you cannot swallow for a while, ask how the dose will be covered.
Never run out
Buy the next strip before the current one ends, especially before travelling from your district to Hyderabad for treatment. Missed days add up. If supply is a problem, tell your doctor early. Government hepatitis programmes may help, and the rules are best checked at the time.
Keep the blood tests going
Viral load and liver tests are checked at follow-up visits. Bring the latest reports to both your liver doctor and your oncologist so neither is working blind.
If yellow eyes or skin appear suddenly, especially with fever, or if the person becomes confused, unusually drowsy, vomits blood or passes black stools, go to hospital today. Say they have hepatitis B and liver cancer, and name the antiviral they take. Do not wait for the next follow-up appointment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often believe about these tablets?
An undetectable result shows the tablets are working. It does not mean the virus has gone. Stopping is what lets it come back, sometimes sharply.
The antiviral protects the liver. Your doctors check how every cancer medicine fits alongside it. Leaving the antiviral out to "rest the liver" is the riskier choice.
The two are linked. A virus flare during cancer care can delay or stop treatment. Keeping hepatitis B controlled is part of treating the cancer, not a distraction from it.
In India it is often passed from mother to baby at birth, long before anyone knew. Nobody is at fault. What helps now is testing and vaccinating relatives. See should my family be tested.
Who this does not apply to
What if I have hepatitis C, or no hepatitis at all?
Hepatitis C works differently. It is curable with a course of tablets that ends. Once the virus has been cleared, there is no daily antiviral to continue. If you have liver cancer and hepatitis C that has not yet been treated, your doctors will decide when to treat it, and our page on hepatitis C treatment when you already have cancer covers that choice.
Clearing the virus does not end follow-up
Whether you have hepatitis B controlled on tablets or hepatitis C that has been cleared, the liver can still grow a new tumour. Scans continue. Our page on why scans continue on treatment explains why.
No viral hepatitis
If your liver cancer came from alcohol, fatty liver or another cause, this page does not apply to you, and there is no antiviral to take. If the cancer in your liver spread there from another organ, follow-up is guided by that original cancer instead.
Being straight with you
What this page cannot tell you
It cannot tell you which antiviral is right for you, whether yours should be changed, or how to take it. Those decisions depend on your viral load, your kidney function, your other medicines and your liver tests. A hepatologist or physician makes them. CION coordinates hepatology care through partner specialists and makes sure your cancer team and liver doctor share the same reports.
Where the evidence is thin
It is clear that stopping hepatitis B treatment can cause flares. How much continuing it lowers the chance of a second tumour in one particular person cannot be predicted. That uncertainty is a reason to keep both the tablets and the scans going, not to drop either.
If you have already stopped your tablets, do not simply restart on your own. Call your liver doctor or the helpline and say so today.Questions we are asked
Common questions about antivirals after liver cancer
How long will I need to take the antiviral?
For most people with hepatitis B and liver cancer, the antiviral is taken long term, often for life. Hepatitis B is controlled, not removed, so the reason to take it does not end. Your liver doctor will review this at each visit rather than set an end date in advance.
Can I take the antiviral with chemotherapy or immunotherapy?
Yes, and it is usually essential. These treatments can wake a sleeping virus. Immunotherapy needs extra care with hepatitis B, explained on our page on immunotherapy with hepatitis B or cirrhosis. Your teams will check the combination.
I am an inactive carrier. Do I need to start an antiviral?
Possibly. Once liver cancer has been diagnosed, or before chemotherapy or steroids, many doctors start an antiviral even in carriers who were not on one. This decision belongs to a hepatologist who has seen your full results. Ask about it before cancer treatment begins.
What happens if I miss a few tablets?
Take the next one as normal and do not double up. Tell your doctor at the next visit. Missing tablets often can let the virus rise or become resistant to the medicine. If you have missed many, call your liver doctor soon rather than waiting.
Do antivirals have side effects?
Most people take them with few problems. Some antivirals need kidney and bone checks over time, which is one reason blood tests continue. If you notice anything new, tell your doctor rather than stopping the tablets yourself.
Will the antiviral stop the cancer coming back?
It lowers the risk of a new tumour from hepatitis B, but it does not remove it. It also does nothing to cancer cells that were already there. That is why follow-up scans and AFP tests continue alongside the tablets.
Should my family be tested and vaccinated?
Yes. Husband or wife, children, parents and siblings can have a simple blood test. Those not infected and not protected can be vaccinated. This is about protecting them, not about blame. Our page on vaccinating the household explains how.
Who should I call if I am unsure about my tablets?
Your hepatologist or physician first, as they prescribe the antiviral. If you are not sure who that is now, or your teams are giving different advice, call the CION helpline. Someone will help you get the right doctors talking to each other.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NHS — Hepatitis B
- World Health Organization — Hepatitis B
- NIDDK — Hepatitis B - NIDDK
- American Cancer Society — Living as a Liver Cancer Survivor
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Are your liver doctor and cancer team on the same page?
Send us your latest viral load, liver tests and list of medicines, and we will help make sure both teams see them. One helpline serves every CION centre.